Abstract
The effects of three vehicles, phosphate-buffered saline (PBS), ethanol (50% in PBS w/w) and propylene glycol (50% in PBS w/w) on in vitro transdermal penetration of testosterone was investigated in the horse. Skin was harvested from the thorax of five Thoroughbred horses after euthanasia and stored at −20°C until required. The skin was then defrosted and placed into Franz-type diffusion cells, which were maintained at approximately 32°C by a water bath. Saturated solutions of testosterone, containing trace amounts of radiolabelled [14C]testosterone, in each vehicle were applied to the outer (stratum corneum) surface of each skin sample and aliquots of receptor fluid were collected at 0, 2, 4, 8, 16, 20, 22 and 24 h and analysed for testosterone by scintillation counting. The maximum flux (J max) of testosterone was significantly higher for all sites when testosterone was dissolved in a vehicle containing 50% ethanol or 50% propylene glycol, compared to PBS. In contrast, higher residues of testosterone were found remaining within the skin when PBS was used as a vehicle. This study shows that variability in clinical response to testosterone could be expected with formulation design.
Similar content being viewed by others
Abbreviations
- A :
-
the exposed cross-sectional area of the membrane
- Δ C :
-
the concentration (counts) differential between compartments
- dC/dt :
-
the steady-state rate of change in the receiver concentration (counts per min)
- EtOH:
-
ethanol
- HPLC:
-
high-performance liquid chromatography
- HSD:
-
honest significant difference
- J max :
-
maximum flux of testosterone
- k P :
-
permeability coefficient
- PBS:
-
phosphate-buffered saline
- PG:
-
propylene glycol
- V R :
-
receiver volume
References
Adams, H., 2001. Veterinary Pharmacology and Therapeutics, 8th edn (Blackwell, Ames, IA)
Aungst, B.J., Blake, J.A. and Hussain, M.A., 1990. Contributions of drug solubilization, partitioning, barrier disruption and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharmaceutical Research, 7(7), 712–718
Barry, B.W., 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. European Journal of Pharmaceutical Sciences, 14(2), 101–114
Cantrill, J.A., Dewis, P., Large, D.M., Newman, M. and Anderson, D.C., 1984. Which testosterone replacement therapy? Clinical Endocrinology (Oxford), 21(2), 97–107
Finnin, B.C. and Morgan, T.M., 1999. Transdermal penetration enhancers: applications, limitations, and potential. Journal of Pharmaceutical Sciences, 88(10), 955–958.
Flynn, G.L., Durrheim, H. and Higuchi, W.I., 1981. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeabilities. Journal of Pharmaceutical Sciences, 70(1), 52–56
Hadgraft, J., 1996. Recent developments in topical and transdermal delivery. European Journal of Drug Metabolism and Pharmacokinetics, 21(2), 165–173
Handelsman, D.J., Conway, A.J. and Boylan, L.M., 1990. Pharmacokinetics and pharmacodynamics of testosterone pellets in man. Journal of Clinical Endocrinology and Metabolism, 71(1), 216–226
Hotchkiss, S.A.M., 1998. Dermal metabolism. In: M.S. Roberts and K.A. Walters (eds), Dermal Absorption and Toxicity Assessment, (Marcel Dekker, New York), 43–101
Hueber, F., Wepierre, J. and Schaefer, H., 1992. Role of transepidermal and transfollicular routes in percutaneous absorption of hydrocortisone and testosterone: in vivo study in the hairless rat. Skin Pharmacology, 5(2), 99–107
Hueber, F., Schaefer, H. and Wepierre, J., 1994. Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacology, 7(5), 237–244
Idson, B., 1983. Vehicle effects in percutaneous absorption. Drug Metabolism Reviews, 14(2), 207–222
Kao, J. and Carver, M.P., 1990. Cutaneous metabolism of xenobiotics. Drug Metabolism Reviews, 22(4), 363–410
Kim, M.K., Lee, C.H. and Kim, D.D., 2000. Skin permeation of testosterone and its ester derivatives in rats. Journal of Pharmacy and Pharmacology, 52(4), 369–375
Mills, P.C., Magnusson, B.M. and Cross, C.E., 2005. The effects of vehicle and region of application on absorption of hydrocortisone through canine skin. American Journal of Veterinary Research, 66(1), 43–47
Monteiro-Riviere, N.A., Inman, A.O., Riviere, J.E., McNeill, S.C. and Francoeur, M.L., 1993. Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharmaceutical Research, 10(9), 1326–1331
Oriba, H.A., Bucks, D.A. and Maibach, H.I., 1996. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. British Journal of Dermatology, 134(2), 229–233
Ostrenga, J., Steinmetz, C. and Poulsen, B., 1971. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy. Journal of Pharmaceutical Sciences, 60(8), 1175–1179
Qiao, G.L. and Riviere, J.E., 1995. Significant effects of application site and occlusion on the pharmacokinetics of cutaneous penetration and biotransformation of parathion in vivo in swine. Journal of Pharmaceutical Sciences, 84(4), 425–432
Riviere, J.E. and Papich, M.G., 2001. Potential and problems of developing transdermal patches for veterinary applications. Advanced Drug Delivery Reviews, 50(3), 175–203
Roberts, M.S., Cross, S.E. and Pellett, M.A., 2002. Skin transport In: K.A. Walters (eds). Dermatological and Transdermal Formulations, (Marcel Dekker, New York), 89–196
Scheuplein, R.J. and Blank, I.H., 1973. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. Journal of Investigative Dermatology, 60(5), 286–296
Snow, D.H., 1993. Anabolic steroids. Veterinary Clinics of North America: Equine Practice, 9(3), 563–576
Snyder, P.J., 1984. Clinical use of androgens. Annual Review of Medicine, 35, 207–217
Surber, C., Wilhelm, K.P., Hori, M., Maibach, H.I. and Guy, R.H., 1990. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharmaceutical Research, 7(12), 1320–1324
Thomas, J. (ed.), 2002. Australian Prescription Products Guide, 31st edn (Pharmaceutics Publishing Company Ltd, Hawthorn)
Tur, E., Maibach, H.I. and Guy, R.H., 1991. Percutaneous penetration of methyl nicotinate at three anatomic sites: evidence for an appendageal contribution to transport? Skin Pharmacology, 4(4), 230–234
Walters, K.A. and Brain, K., 2002. Dermatological formulation and transdermal systems. In: K.A. Walters (ed), Dermatological and Transdermal Formulations, (Marcel Dekker, New York), 319–399
Walters, K.A. and Roberts, M.S., 2002. The structure and function of skin. In: K.A. Walters (ed), Dermatological and Transdermal Formulations, (Marcel Dekker, New York), 1–40
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mills, P.C. Vehicle Effects on the In Vitro Penetration of Testosterone through Equine Skin. Vet Res Commun 31, 227–233 (2007). https://doi.org/10.1007/s11259-006-3446-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-006-3446-6